NDA submissions for NCX 470 are planned for the first half of 2026 in the US, with China following shortly after. NCX 470 is ...

Iyuzeh is a preservative-free prostaglandin F2α analogue. The Food and Drug Administration (FDA) has approved Iyuzeh ™ (latanoprost ophthalmic solution) 0.005% for the reduction of elevated ...

Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

(a) Mechanism for the feel of softness by a human fingertip. (b) Structure of the indentor. The two sensors are integrated on the sphere surface. (c) Multi-segment displacement control of the indentor ...

Omlonti is a relatively selective EP2 receptor agonist designed to increase aqueous humor drainage through the conventional (or trabecular) and uveoscleral outflow pathways. The Food and Drug ...